Mads Hald Andersen

Mads Hald Andersen

Clinical Professor

Member of:

    ORCID: 0000-0002-2914-9605

    Publication year:
    All
    11 - 13 out of 13Page size: 10
    1. 2011
    2. Published

      HLA-A2-restricted survivin-derived T-cell responses

      Straten, P. T. & Andersen, Mads Hald, 2011, In: Vaccine. 29, 52, p. 9582

      Research output: Contribution to journal › Letter › Research › peer-review

    3. Published

      Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors

      Andersen, R. S., Sørensen, R. B., Ritter, C., Svane, Inge Marie, Becker, J. C., thor Straten, P. & Andersen, Mads Hald, 2011, In: Cancer Immunology, Immunotherapy. 60, 2, p. 227-34 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Submitted

      IkB based Immunotherapy

      Andersen, Mads Hald, 2011, (Submitted) 26 Oct 2011

      Research output: Patent

    Previous 1 2 Next

    ID: 13571778